sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Transthyretin Amyloidosis Treatment Market Scope And Analysis

  • Report Code : TIPRE00040762
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Transthyretin Amyloidosis Treatment Market Analysis and Scope (2025 to 2031)

Buy Now

Transthyretin Amyloidosis Treatment Market Report Transthyretin Amyloidosis Treatment Market Size and Share Transthyretin Amyloidosis Treatment Market Scope and Analysis

Transthyretin Amyloidosis Treatment Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 7.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • ATTR-CM
  • ATTR-PN
By Disease Type
  • Hereditary
  • Wild Type
By Drug Type
  • Tafamidis
  • Patisiran
By Distribution Channel
  • Hospital Pharmacy
  • Retail Drug Store
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Acrotech Biopharma LLC
  • Alnylam Pharmaceuticals Inc
  • AstraZeneca PLC
  • Astellas Pharma Inc
  • BridgeBio Pharma Inc
  • Bristol Myers Squibb Company
  • Ionis Pharmaceuticals Inc
  • Johnson Johnson
  • Prothena Biosciences Limited
  • Pfizer Inc